Targeted AntiBiotics for Chronic Pulmonary Diseases

NCT03262142 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

51

Enrollment

OTHER

Sponsor class

Stopped Slow recruitment

Conditions

COPD
Respiratory Tract Infections
Pseudomonas Aeruginosa
Bronchiectasis
Asthma

Interventions

DRUG: Piperacillin/tazobactam
DRUG: Ciprofloxacin

Sponsor

Chronic Obstructive Pulmonary Disease Trial Network, Denmark

Collaborators

[object Object]